logo
Book a meeting
Vivtex

Vivtex

Biotechnology, 790 Memorial Dr, Cambridge, Massachusetts, 02139, United States, 11-50 Employees

vivtex.com

  • LinkedIn

Who is VIVTEX

Vivtex strives to transform drug development using a new platform technology called gastrointestinal tract organ robotic interface system (GI-ORISTM) that enables robotic screening with f...

Read More

lock icon Get Full Access
map
  • 790 Memorial Dr, Cambridge, Massachusetts, 02139, United States Headquarters: 790 Memorial Dr, Cambridge, Massachusetts, 02139, United States
  • 2018 Date Founded: 2018
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from VIVTEX

Vivtex Org Chart and Mapping

Employees
Luke Sepich

Luke Sepich

Research Associate II

Douglas Huynh

Douglas Huynh

Research Associate III

See Full Org Chart arrow
email-formate-icon
View Email Formats for Vivtex
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Vivtex

Answer: Vivtex's headquarters are located at 790 Memorial Dr, Cambridge, Massachusetts, 02139, United States

Answer: Vivtex's official website is https://vivtex.com

Answer: Vivtex's revenue is $5 Million to $10 Million

Answer: Vivtex's SIC: 2834

Answer: Vivtex has 11-50 employees

Answer: Vivtex is in Biotechnology

Answer: Vivtex contact info: Phone number: Website: https://vivtex.com

Answer: Vivtex strives to transform drug development using a new platform technology called gastrointestinal tract organ robotic interface system (GI-ORISTM) that enables robotic screening with fully intact and functional organs. GI-ORISTM technology was developed in the Langer lab at MIT and can be used for various applications (e.g. oral delivery of biologics, drug toxicity mitigation, spatial and temporal drug delivery). Vivtex leverages these unique capabilities of the GI-ORISTM to develop new oral therapeutics. Vivtex's mission is to serve patients by increasing the efficacy, safety and adherence of existing and novel therapies. The company is in preclinical stage and has multiple drug development programs including reformulations of existing drugs as well as new chemical entities. The company was co-founded by Professor Robert Langer (MIT), Dr. Giovanni Traverso (Harvard Medical School), Doug Eby (Cambridge Science), and Thomas von Erlach.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access